MiMedx Group, Inc.
MDXG
$7.08
-$0.23-3.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.85% | 5.34% | 8.52% | 10.93% | 15.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.85% | 5.34% | 8.52% | 10.93% | 15.41% |
| Cost of Revenue | 19.47% | 15.29% | 9.96% | 3.34% | 7.45% |
| Gross Profit | 4.34% | 3.37% | 8.23% | 12.58% | 17.14% |
| SG&A Expenses | 14.78% | 2.36% | 0.04% | -2.09% | -4.60% |
| Depreciation & Amortization | -23.26% | -11.55% | 0.13% | 1.33% | 3.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.66% | 5.03% | 1.83% | 1.11% | -1.12% |
| Operating Income | -31.72% | 7.11% | 59.81% | 93.27% | 330.52% |
| Income Before Tax | -23.60% | 24.05% | 87.04% | 125.60% | 560.94% |
| Income Tax Expenses | 142.75% | 142.12% | 141.55% | -4,444.13% | -49,825.86% |
| Earnings from Continuing Operations | -63.19% | -49.06% | -37.72% | 230.43% | 896.35% |
| Earnings from Discontinued Operations | -89.59% | 103.70% | 104.57% | 122.89% | 118.80% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.81% | -44.56% | -27.15% | 1,939.61% | 804.25% |
| EBIT | -31.72% | 7.11% | 59.81% | 93.27% | 330.52% |
| EBITDA | -19.61% | 16.36% | 61.20% | 85.12% | 262.87% |
| EPS Basic | -65.59% | -46.54% | -25.83% | 2,871.49% | 473.69% |
| Normalized Basic EPS | -31.56% | 2.24% | 54.52% | 90.48% | 475.68% |
| EPS Diluted | -65.06% | -44.86% | -23.25% | 4,401.45% | 472.57% |
| Normalized Diluted EPS | -24.81% | 20.70% | 95.35% | 110.31% | 560.74% |
| Average Basic Shares Outstanding | 11.26% | 18.20% | 26.13% | 21.89% | 15.94% |
| Average Diluted Shares Outstanding | -0.03% | 0.24% | 6.69% | 13.63% | 22.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |